Pacira Pharmaceuticals, Inc. share price logo

Pacira Pharmaceuticals, Inc. Share Price

NASDAQ: PCRX

Small Cap

$27.11

+0.08

(+0.30%)

as on

Pacira Pharmaceuticals, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $26.6
    $27.46
    downward going graph

    1.88%

    Downside

    1.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.84
    $27.64
    downward going graph

    52.64%

    Downside

    1.95%

    Upside

    downward going graph

Pacira Pharmaceuticals, Inc. share price movements today

Previous Close
$27.03
Open
$26.86
Volume
556.1K
Day's Low - High
$26.6 - $27.46
52 Week Low - High
$12.84 - $27.64

Pacira Pharmaceuticals, Inc. Historical Returns

1 Month Return
+ 8.31 %
3 Month Return
+ 11.88 %
1 Year Return
+ 106.86 %
3 Year Return
-51.58 %
5 Year Return
-52.91 %

Pacira Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Pacira Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

2.869

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.48%

PE Ratio (TTM)

11.14

Industry PE ratio

-3.773885542168675

P/B Ratio

0

PEG Ratio

-3.83

EBITDA

158.4M

Revenue (TTM)

705.8M

Profit Margin

-18.06%

Return On Equity TTM

33483300.00%

Pacira Pharmaceuticals, Inc. Stock Valuation

Track how Pacira Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Pacira Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (5.36x)

September 30, 2024

Industry (-3.77x)

September 13, 2025

Today (11.14x)

September 13, 2025

Highest (32.47x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 11.14x

Pacira Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.2B-52.91%11.14-18.06%
BUY$18.3BNA15.840.36%
BUY$44.2BNA21.9313.81%
BUY$14.1B41.32%41.9713.88%
BUY$65.7B-6.55%25.5127.83%

Stock Returns calculator for Pacira Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Pacira Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pacira Pharmaceuticals, Inc. investment value today

Current value as on today

₹2,11,928

Returns

₹1,11,928

(+111.93%)

Returns from Pacira Pharmaceuticals, Inc. Stock

₹1,06,789 (+106.79%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Pacira Pharmaceuticals, Inc. Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Pacira Pharmaceuticals, Inc.. Average target price of $29

Pacira Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Pacira Pharmaceuticals, Inc..

What analysts predicted

6.52%UPSIDE

Target Price

$29

Current Price

$27.11

Analyzed by

16 Analysts

Target

$29.00

Pacira Pharmaceuticals, Inc. target price $29, a slight upside of 6.52% compared to current price of $27.11. According to 16 analysts rating.

Pacira Pharmaceuticals, Inc. Stock's Interest Amongst Investors

Search interest for Pacira Pharmaceuticals, Inc. Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Pacira Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
160
169
163
181
167
178
168
187
168
181
Gross Profit
111
121
124
119
105
119
129
147
134
140
Operating Income
12
39
17
33
15
30
-139
24
1
8
EBITDA
2
42
39
52
35
49
-114
51
33
29
Interest Expense
9
3
3
3
3
3
4
4
4
3
Depreciation
14
14
14
18
18
18
20
21
21
27
Income Before Tax
-26
37
16
33
13
36
-138
25
8
-1
Income Tax Expense
-6
12
5
8
4
17
4
9
3
2
Net Income
-19
25
10
24
8
18
-143
16
4
-4
Net Profit Margin
-12.18%
15.20%
6.62%
13.72%
5.37%
10.61%
-85.11%
8.57%
2.85%
-2.68%

Pacira Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
248
276
286
337
421
420
541
666
674
700
Gross Profit
177
166
198
250
314
303
401
467
490
530
Operating Income
9
-32
-24
15
38
46
131
60
87
-73
EBITDA
21
-17
-10
33
55
71
118
144
157
29
Interest Expense
7
7
18
21
23
25
31
39
20
16
Depreciation
-
-
13
13
19
19
13
91
87
78
Income Before Tax
2
-37
-42
0
-10
20
56
13
61
-63
Income Tax Expense
0
0
0
0
0
-125
14
-2
19
36
Net Income
1
-37
-42
0
-11
145
41
15
41
-99
Net Profit Margin
0.75%
-13.73%
-14.87%
-0.14%
-2.62%
34.58%
7.75%
2.39%
6.22%
-14.20%

Pacira Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
25
10
24
8
18
-143
16
4
-4
Operating Cash Flow
43
44
47
49
53
53
33
35
12
Investing Cash Flow
7
-4
8
-15
-15
-52
0
-25
62
Financing Cash Flow
0
-27
-1
-2
24
-2
-1
-2
-57
Change in Cash
51
12
54
30
63
-1
30
6
16

Pacira Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-37
-42
0
-11
145
41
15
41
-99
Operating Cash Flow
33
17
48
70
77
125
145
154
189
Investing Cash Flow
-61
-223
20
-128
-277
-20
-225
77
-83
Financing Cash Flow
7
224
8
3
222
380
-401
-183
17
Change in Cash
-21
18
78
-54
21
485
-481
49
123

Global Institutional Holdings in Pacira Pharmaceuticals, Inc.

Funds
Holdings
BlackRock Inc
17.05%
Vanguard Group Inc
11.68%
D. E. Shaw & Co LP
5.04%
Renaissance Technologies Corp
4.99%
Dimensional Fund Advisors, Inc.
4.56%

Insights on Pacira Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 168.92M → 181.09M (in $), with an average increase of 6.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PCRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, PCRX stock has moved up by 107.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 85.0% return, outperforming this stock by 135.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 16.04M → -4.84M (in $), with an average decrease of 135.4% per quarter

About Pacira Pharmaceuticals, Inc.

pacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012. exparel and two other products have utilized the pacira proprietary product delivery technology depofoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.
OrganisationPacira Pharmaceuticals, Inc.
Headquarters5401 West Kennedy Boulevard, Tampa, FL, United States, 33609
IndustryHealth Technology
CEOMr. Frank D. Lee
E-voting on sharesClick here to vote

Key Management of Pacira Pharmaceuticals, Inc.

Name

Title

Mr. Frank D. Lee

CEO & Director

Mr. Shawn M. Cross

Chief Financial Officer

Ms. Lauren Bullaro Riker

Principal Accounting Officer & Senior VP of Finance

Ms. Kristen Williams Esq., J.D.

Chief Administrative Officer & Secretary

FAQs

What is Pacira Pharmaceuticals, Inc. share price today?

Pacira Pharmaceuticals, Inc. share price today is $27.11 as on at the close of the market. Pacira Pharmaceuticals, Inc. share today touched a day high of $27.46 and a low of $26.6.

What is the 52 week high and 52 week low for Pacira Pharmaceuticals, Inc. share?

Pacira Pharmaceuticals, Inc. share touched a 52 week high of $27.64 on and a 52 week low of $12.84 on . Pacira Pharmaceuticals, Inc. stock price today i.e. is closed at $27.11,which is 1.92% down from its 52 week high and 111.14% up from its 52 week low.

What is Pacira Pharmaceuticals, Inc.'s market capitalisation today?

Pacira Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pacira Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacira Pharmaceuticals, Inc. Shares that will get you 0.0553 shares as per Pacira Pharmaceuticals, Inc. share price of $27.11 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pacira Pharmaceuticals, Inc. Stock (PCRX) from India?

Indian investors can start investing in Pacira Pharmaceuticals, Inc. (PCRX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Pacira Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Pacira Pharmaceuticals, Inc. share’s latest price of $27.11 as on September 13, 2025 at 1:29 am IST, you will get 0.3689 shares of Pacira Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Pacira Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Pacira Pharmaceuticals, Inc. stock has given -52.91% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?